BCL2 and cholangiocarcinoma: As we found, CBD inhibited CCA growth by reducing phosphorylation of the PI3K/AKT/mTOR pathway in relation to a decrease in the expression of Bcl-2, a protein involved in cell survival, and an increase in autophagy.